Chinese Ministry of Commerce approves Nestle's US$11.85B bid to buy Pfizer's infant nutrition business; Nestle still needs approvals from anti-trust bodies in several other countries
Nevin Barich
LOS ANGELES
,
November 2, 2012
(Industry Intelligence Inc.)
–
The Chinese Ministry of Commerce has approved Nestle SA's US$11.85 billion bid to buy Pfizer's infant nutrition business, Dow Jones Newswires reported Nov. 2.
Nestle still needs approvals from anti-trust bodies in several other countries.
The primary source of this article is Dow Jones Newswires, New York, New York, on Nov. 2, 2012.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
